Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Jul 22, 2003
TARRYTOWN, N.Y., and GLASGOW, Scotland, July 22 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS), a biopharmaceutical company pioneering the oral delivery of otherwise injectable or inhaled drugs, today announced the presentation of three posters at the 30th Annual Meeting & Exposition of the Controlled Release Society ...
Jun 20, 2003
TARRYTOWN, N.Y., June 20 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced that an audio feed of its corporate presentation at the 2003 Biotechnology Industry Organization (BIO) Annual Convention's Business Forum (Partnering Forum and Investor Forum) will be webcast live over the Internet. Emisphere's presen...
Jun 19, 2003
TARRYTOWN, N.Y., Jun 19, 2003 /PRNewswire-FirstCall via COMTEX/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) announced today that it has signed a cooperative research and development agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the U.S. Department of Defense's lead laboratory for medical...
Jun 16, 2003
TARRYTOWN, N.Y., and NEW ORLEANS, June 16 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) along with its clinical collaborators, announced today promising results from two clinical studies evaluating an oral insulin prototype, both of which were presented at the 63rd Annual Scientific Sessions of the American Diabetes Asso...
Jun 11, 2003
TARRYTOWN, N.Y., Jun 11, 2003 /PRNewswire-FirstCall via COMTEX/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS), a biopharmaceutical company pioneering the oral delivery of otherwise injectable or inhaled drugs, announced today that two separate oral insulin clinical studies in type 2 diabetic patients will be presented at the 63rd Annual Scie...
Jun 3, 2003
TARRYTOWN, N.Y.--(BUSINESS WIRE)--June 3, 2003--Emisphere Technologies, Inc. (Nasdaq:EMIS) will be presenting at the White Mountain Capital 2003 Biotechnology Conference on Thursday, June 5, 2003, at 4:15 p.m. EDT. The one-day conference will be held at the IBM Palisades Conference Center in Palisades, NY. For those unable to attend...
Jun 3, 2003
TARRYTOWN, N.Y., Jun 3, 2003 /PRNewswire-FirstCall via COMTEX/ -- Emisphere Technologies, Inc. will be presenting at the UBS Warburg Global Specialty Pharmaceuticals Conference on Wednesday, June 4, 2003, at 2:30 p.m. EDT. The two-day conference will be held at the Grand Hyatt Hotel in New York, NY, June 4-5, 2003. For those unabl...
May 27, 2003
TARRYTOWN, N.Y., May 27 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. will be presenting at the Friedman Billings Ramsey 7th Annual Technology & Growth Investor Conference on Thursday, May 29, 2003, at 9:20 a.m. EDT. The two-day conference, which will be held at the Millennium Hotel Broadway in New York, New York, features more tha...
May 13, 2003
TARRYTOWN, N.Y.--(BUSINESS WIRE)--May 13, 2003--Emisphere Technologies, Inc. (NASDAQ:EMIS) will host its annual shareholders meeting on May 15, 2003 at the Westchester Marriott Hotel in Tarrytown, NY, beginning at 10:00 a.m., Eastern Daylight Time. ONSITE ATTENDANCE INFORMATION: For those traveling from New York City, Emi...
May 8, 2003
TARRYTOWN, N.Y., May 8 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced financial results for the first quarter ended March 31, 2003. The Company also provided an update on development programs involving its proprietary eligen™ oral drug delivery technology. ...
May 8, 2003
Tarrytown, NY, May 8, 2003 --- Emisphere Technologies, Inc. (NASDAQ: EMIS) announced today that it is initiating clinical testing of an oral insulin formulation in type 2 diabetic patients in the United States under an Investigational New Drug (IND) application filed with the United States Food and Drug Administration (FDA). The formulation use...
May 1, 2003
TARRYTOWN, N.Y.--(BUSINESS WIRE)--May 1, 2003--Emisphere Technologies, Inc. (Nasdaq: EMIS) will hold a conference call to discuss the Company's first quarter financial results for the quarter ending March 31, 2003. The call will be held on Thursday, May 8, 2003, beginning at 10:30 a.m. Eastern Time (7:30 a.m. Pacific). A replay of the call wil...
Mar 6, 2003
SALT LAKE CITY, Mar 6, 2003 /PRNewswire-FirstCall via COMTEX/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today presented data from a clinical study in patients with type II diabetes that evaluated a capsule preparation of insulin using its eligen™ oral drug delivery technology. The data was presented at...
Mar 5, 2003
TARRYTOWN, N.Y., Mar 5, 2003 /PRNewswire-FirstCall via COMTEX/ --Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced a delay related to a previously disclosed near-term milestone to secure a partnership for its oral insulin candidate. Emisphere held a conference call and webcast at 8:00 am Eastern time on March 5, 2003 to discuss the ba...
Mar 4, 2003
TARRYTOWN, N.Y., Mar 4, 2003 (BUSINESS WIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS) announced today that it will host a conference call and webcast at 8:00 a.m., Eastern Standard Time, on Wednesday, March 5, 2003 to discuss the status of an oral insulin partnership. To access the live call or the seven-day archive via the internet, ...

= add release to Briefcase

FOLLOW US